Emerging Infectious Diseases (Nov 2018)

Candida auris in South Africa, 2012–2016

  • Nelesh P. Govender,
  • Rindidzani E. Magobo,
  • Ruth Mpembe,
  • Mabatho Mhlanga,
  • Phelly Matlapeng,
  • Craig Corcoran,
  • Chetna Govind,
  • Warren Lowman,
  • Marthinus Senekal,
  • Juno Thomas

DOI
https://doi.org/10.3201/eid2411.180368
Journal volume & issue
Vol. 24, no. 11
pp. 2036 – 2040

Abstract

Read online

To determine the epidemiology of Candida auris in South Africa, we reviewed data from public- and private-sector diagnostic laboratories that reported confirmed and probable cases of invasive disease and colonization for October 2012–November 2016. We defined a case as a first isolation of C. auris from any specimen from a person of any age admitted to any healthcare facility in South Africa. We defined probable cases as cases where the diagnostic laboratory had used a nonconfirmatory biochemical identification method and C. haemulonii was cultured. We analyzed 1,692 cases; 93% were from private-sector healthcare facilities, and 92% of cases from known locations were from Gauteng Province. Of cases with available data, 29% were invasive infections. The number of cases increased from 18 (October 2012–November 2013) to 861 (October 2015–November 2016). Our results show a large increase in C. auris cases during the study period, centered on private hospitals in Gauteng Province.

Keywords